Emcure Pharmaceuticals opens new R&D centre in Gujarat, India
Emcure Pharmaceuticals has opened its new formulation research and development (R&D) centre in Ahmedabad, in the Indian state ...
Rigel enrols first subject in Phase I sickle cell disease therapy trial
Rigel Pharmaceuticals has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, ...